MBL-HCV1

BIOLOGICAL3 trials

Sponsors

MassBiologics

Conditions

HCV InfectionHealthyHepatitis C InfectionLiver Transplantation

Phase 1

Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C

CompletedNCT00952263

MassBiologicsHealthy

Start: 2009-07-31End: 2009-12-31Updated: 2016-09-15

Phase 2

Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

TerminatedNCT01121185

MassBiologicsHCV Infection, Liver Transplantation

Start: 2010-06-30End: 2011-06-30Updated: 2016-06-14

Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C

TerminatedNCT01532908

MassBiologicsHepatitis C Infection

Start: 2012-11-21End: 2015-08-27Updated: 2021-02-05

Related Papers

Treatment of <scp>HCV</scp> prior to liver transplantation to prevent <scp>HCV</scp> recurrence – Wise or wasteful?

Liver International2014-11-203 citations